Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.745,52
-0,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ProPhase Labs Inc (PRPH) ProPhase Labs Inc (PRPH) Notizie

ProPhase Labs Inc

PRPH
5,42
0,11 (2,07%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:00GLOBEPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL..
25/4/202414:00GLOBEProPhase Labs to Present at the Planet MicroCap Showcase:..
16/4/202414:00GLOBEProPhase Labs Unveils Project ZenQ-AI
10/4/202414:00GLOBEProPhase Labs Seeks to Transform Esophageal Cancer Detection..
02/4/202403:00GLOBEProPhase Labs Announces Inducement Grant Under Nasdaq..
15/3/202413:00GLOBEProPhase Labs Announces Financial Results for the Year Ended..
08/3/202414:00GLOBEPROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON..
20/2/202414:00GLOBEProPhase Labs Announces Significant Progress in BE-Smart..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:00GLOBEProPhase Labs Announces Preliminary Positive Results for..
30/1/202414:00GLOBEProPhase Labs Ushers in New Genomics Era with Jason Karkus..
23/1/202414:00GLOBEPharmaloz Manufacturing Accelerates Expansion, Improves..
04/1/202414:05EDGAR2Form 8-K - Current report
04/1/202414:00GLOBEProPhase poised to ramp up growth at Pharmaloz and Nebula..
13/11/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:00EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
02/11/202313:00GLOBEProPhase Labs to Host Third Quarter 2023 Financial Results..
17/10/202314:00GLOBEProPhase Labs Announces Substantial Growth Expectations for..
12/10/202314:25GLOBEDSS Inc. Issues Letter to Shareholders
12/10/202314:00GLOBEProPhase Labs to Present at The ThinkEquity Conference
11/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202316:40GLOBEProPhase Labs Announces Updated Conference Call Dial-in..
10/8/202314:00EDGAR2Form 8-K - Current report
10/8/202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
03/8/202314:00GLOBEProPhase Labs Teams up with Certis Oncology to Accelerate..
02/8/202314:00GLOBEProPhase Labs to Host Second Quarter 2023 Financial Results..
29/6/202314:05EDGAR2Form 8-K - Current report
29/6/202314:00GLOBENavidea Biopharmaceuticals Rejects ProPhase Labs Offer To..
22/6/202314:30GLOBEProPhase Labs Inc. Sets the Course for Expansion into the..
07/6/202314:00GLOBEProPhase Labs to Present at the Diamond Equity Research..
01/6/202314:30GLOBEProPhase Labs’ Cancer Therapeutic, Linebacker-1,..
11/5/202314:00GLOBEProPhase Labs Announces Financial Results for the Three..
08/5/202314:30GLOBEProPhase Labs hires Dr. Matthew Halpert to Drive Company’s..
Apertura: 5,30 Min: 5,20 Max: 5,50
Chiusura: 5,31

La tua Cronologia

NASDAQ
PRPH
ProPhase Labs
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network